Success of Big Infectious Disease Reimbursement Policy in China
Big infectious diseases do harm to the whole society, and it is highly crucial to control them on time. The major purpose of this article is to theoretically demonstrate that the Chinese government’s intervention in large-scale infectious diseases is successful and efficient. Two potential strategie...
Main Authors: | Kun-xi Nie, Chan Wang, Xin-wu Li |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-02-01
|
Series: | Inquiry: The Journal of Health Care Organization, Provision, and Financing |
Online Access: | https://doi.org/10.1177/0046958020907788 |
Similar Items
-
The Dilemma of Medical Reimbursement Policy in Rural China: Spatial Variability between Reimbursement Region and Medical Catchment Area
by: Yongqing Dong, et al.
Published: (2019-08-01) -
BIG DATA IN HEALTHCARE: Real World Evidence in price and reimbursement
by: Juliette Marie Monpays
Published: (2019) -
The Reality and Recommendations for The Reimbursement Policy of Rare Diseases in the National Health Insurance Program
by: Sung,Chun-Yi, et al.
Published: (2017) -
Teledermatology: An updated overview of clinical applications and reimbursement policies
by: M. Campagna, et al.
Published: (2017-09-01) -
Exploration of the Influences of Drug Reimbursement Policy on Antihypertensive Agent
by: Su-Jing Chen, et al.
Published: (2010)